Diederik holds an MSc degree in medicine from Leiden University, and has more than 25 years of experience in the life science industry. He has held holding various international and executive positions in strategic marketing, R&D, business
We are dedicated to developing a vaccine that can cure cancer We are dedicated to developing a vaccine that can cure cancer We are dedicated to developing a vaccine that can cure cancer We are dedicated to developing a vaccine that can cure…
The Clinical phase will start in Q1 2025. CimCure’s partner, the Dutch vaccine contract development and manufacturing organisation (CDMO) Intravacc, is currently producing the lead compound. The company will continue to work on next-generat…
The research that led to CimCure’s technology started in 1994 in the Angiogenesis Laboratory, that is currently located at Amsterdam UMC. While studying a strategy to help white blood cells enter a tumour, it was discovered that blood vesse…
Despite having different properties than a normal cell, a cancer cell is difficult to recognise because even if the cell is damaged it still looks like a normal cell. Additionally, like every other cell, the cancer cell contains DNA and thi…
Professor of oncology at Amsterdam UMC Arjan Griffioen has already started a company four times before, trying to market a drug. Now he takes a different approach. He never came as far as now. Arjan Griffioen, professor of experimental onco…